{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:05:17Z","timestamp":1790647517739,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peripheral immune dysregulation has increasingly been associated with cognitive impairment and dementia, yet large-scale prospective evidence linking cellular immunophenotypes to long-term cognitive outcomes in community-representative older adults remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We profiled 24 peripheral immune subsets by flow cytometry in 9008 older adults from the Health and Retirement Study (HRS). Among 4464 participants classified as cognitively normal (CN) at baseline, we prospectively examined incident CIND\/dementia (CIND, cognitively impaired no dementia) and six-year cognitive trajectories, constructed an Immune Risk Score (IRS) from baseline peripheral immune-cell features using bootstrap stability-selected elastic-net Cox regression, and characterised correlations with plasma biomarkers related to amyloid, tau, neural injury, astroglial activation, and inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants classified as CIND\/dementia were characterised by a coordinated immunosenescence signature of na\u00efve CD4+ and CD8+ T-cell and na\u00efve B-cell depletion, with expansion of effector-memory T-cell and memory B-cell. CD56hi NK cells and na\u00efve B cells independently predicted reduced cognitive impairment risk after full covariate adjustment (HR\u2009=\u20090.92, 95% CI: 0.86\u20130.98 and HR\u2009=\u20090.92, 95% CI: 0.87\u20130.98). Higher IRS independently predicted incident CIND\/dementia (HR\u2009=\u20091.63; 95% CI, 1.28\u20132.09) and faster decline across global cognition, episodic memory, and working memory and correlated more strongly with GDF-15, NfL, and GFAP than with amyloid or tau pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Peripheral immune profiles independently predict incident CIND\/dementia and multi-domain cognitive decline in older adults, with associations preferentially reflecting neuroinflammatory rather than amyloid-tau burden. These findings support further evaluation of peripheral immunophenotyping as a complementary approach to cognitive impairment risk assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag289","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:23:59Z","timestamp":1789903439000},"source":"Crossref","is-referenced-by-count":0,"title":["Peripheral immune signatures predict cognitive decline in older adults: a population-based cohort study"],"prefix":"10.1093","volume":"55","author":[{"given":"Heya","family":"Luan","sequence":"first","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7380-7451","authenticated-orcid":false,"given":"Cuibai","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology - Innovation Center for Neurological Disorders, Xuanwu Hospital Capital Medical University , Beijing 100053 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026092821512343700_ref1","doi-asserted-by":"publisher","first-page":"0377","DOI":"10.34133\/hds.0377","article-title":"Projected prevalence and economic burden of Alzheimer's disease and related dementias in China: regional disparities and policy implications","volume":"5","author":"Liu","year":"2025","journal-title":"Health Data Sci"},{"key":"2026092821512343700_ref2","doi-asserted-by":"publisher","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026092821512343700_ref3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13195-023-01304-8","article-title":"Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease","volume":"15","author":"Blanco","year":"2023","journal-title":"Alzheimer's Res Ther"},{"key":"2026092821512343700_ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41540-026-00665-8","article-title":"Genetic risk in Alzheimer\u2019s disease","volume":"12","author":"Pan","year":"2026","journal-title":"npj Syst Biol Appl"},{"key":"2026092821512343700_ref5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates a\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"2026092821512343700_ref6","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","article-title":"Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review","volume":"30","author":"Heneka","year":"2025","journal-title":"Mol Psychiatry"},{"key":"2026092821512343700_ref7","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41380-024-02809-w","article-title":"Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival","volume":"30","author":"Strauss","year":"2025","journal-title":"Mol Psychiatry"},{"key":"2026092821512343700_ref8","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1038\/s41467-024-52396-1","article-title":"Clearance and transport of amyloid \u03b2 by peripheral monocytes correlate with Alzheimer\u2019s disease progression","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"key":"2026092821512343700_ref9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature."},{"key":"2026092821512343700_ref10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-024-00726-8","article-title":"Adaptive immune changes associate with clinical progression of Alzheimer's disease","volume":"19","author":"Olst","year":"2024","journal-title":"Mol Neurodegener"},{"key":"2026092821512343700_ref11","doi-asserted-by":"publisher","first-page":"e70952","DOI":"10.1002\/alz.70952","article-title":"A systems immunology analysis of Alzheimer's disease reveals an age- and environmental exposure-independent disturbance in B cell maturation","volume":"21","author":"Humblet-Baron","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026092821512343700_ref12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ana.26817","article-title":"Proteomic indicators of health predict Alzheimer's disease biomarker levels and dementia risk","volume":"95","author":"Dark","year":"2024","journal-title":"Ann Neurol"},{"key":"2026092821512343700_ref13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ije\/dyu067","article-title":"Cohort profile: the health and retirement study (HRS)","volume":"43","author":"Sonnega","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2026092821512343700_ref14","volume-title":"(RAND HRS Longitudinal File 2022 (V1)) Public Use Dataset","author":"Health and Retirement Study","year":"2025"},{"key":"2026092821512343700_ref15","volume-title":"RAND HRS Longitudinal File 2022 (V1)","author":"RAND Center for the Study of Aging","year":"2025"},{"key":"2026092821512343700_ref16","volume-title":"Flow Cytometry Results from the 2016 Venous Blood Study in the 2016 Health and Retirement Study","author":"Thyagarajan","year":"2021"},{"key":"2026092821512343700_ref17","volume-title":"Comparison of the 2016 HRS Core Sample (Age 56+), HRS Venous Blood Study Sample, and Other National Surveys","author":"Stacey Collins","year":"2026"},{"key":"2026092821512343700_ref18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jim.2018.09.007","article-title":"Effect of delayed cell processing and cryopreservation on immunophenotyping in multicenter population studies","volume":"463","author":"Thyagarajan","year":"2018","journal-title":"J Immunol Methods"},{"key":"2026092821512343700_ref19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026092821512343700_ref20","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1002\/cpcy.35","article-title":"A practical cryopreservation and staining protocol for Immunophenotyping in population studies","volume":"84","author":"Barcelo","year":"2018","journal-title":"Curr Protoc Cytom"},{"key":"2026092821512343700_ref21","doi-asserted-by":"publisher","first-page":"8759","DOI":"10.1038\/s41598-020-65016-x","article-title":"Validation of a hybrid approach to standardize immunophenotyping analysis in large population studies: the health and retirement study","volume":"10","author":"Hunter-Schlichting","year":"2020","journal-title":"Sci Rep"},{"key":"2026092821512343700_ref22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/geronb\/gbac172","article-title":"Identifying cognitive impairment among older participants in a nationally representative internet panel","volume":"78","author":"Gatz","year":"2023","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"2026092821512343700_ref23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000255464","article-title":"Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia","volume":"34","author":"Knopman","year":"2010","journal-title":"Neuroepidemiology."},{"key":"2026092821512343700_ref24","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41380-023-02355-x","article-title":"Peripheral immune function and Alzheimer's disease: a living systematic review and critical appraisal","volume":"29","author":"Li","year":"2024","journal-title":"Mol Psychiatry"},{"key":"2026092821512343700_ref25","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awaf167","article-title":"Altered T-cell reactivity in the early stages of Alzheimer's disease","volume":"148","author":"Rickenbach","year":"2025","journal-title":"Brain."},{"key":"2026092821512343700_ref26","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/JAD-230784","article-title":"Characteristics of T cells in single-cell datasets of peripheral blood and cerebrospinal fluid in Alzheimer\u2019s disease patients","volume":"99","author":"Wang","year":"2024","journal-title":"J Alzheimer's Dis"},{"key":"2026092821512343700_ref27","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41380-022-01446-5","article-title":"Peripheral immunity is associated with the risk of incident dementia","volume":"27","author":"Zhang","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026092821512343700_ref28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0047-6374(97)00151-6","article-title":"Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study","volume":"102","author":"Wikby","year":"1998","journal-title":"Mech Ageing Dev"},{"key":"2026092821512343700_ref29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/gerona\/60.5.556","article-title":"An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans","volume":"60","author":"Wikby","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026092821512343700_ref30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3233\/JAD-150749","article-title":"Evaluation of a genetic risk score to improve risk prediction for Alzheimer's disease","volume":"53","author":"Chouraki","year":"2016","journal-title":"J Alzheimer's Dis"},{"key":"2026092821512343700_ref31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"key":"2026092821512343700_ref32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12979-024-00443-2","article-title":"Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort","volume":"21","author":"Winford","year":"2024","journal-title":"Immun Ageing"},{"key":"2026092821512343700_ref33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"key":"2026092821512343700_ref34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-024-03040-8","article-title":"The role of CD56bright NK cells in neurodegenerative disorders","volume":"21","author":"Rodriguez-Mogeda","year":"2024","journal-title":"J Neuroinflammation"},{"key":"2026092821512343700_ref35","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026092821512343700_ref36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1474-4422(10)70033-8","article-title":"Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta","volume":"9","author":"Wynn","year":"2010","journal-title":"Lancet Neurol"},{"key":"2026092821512343700_ref37","doi-asserted-by":"publisher","first-page":"25424823251329188","DOI":"10.1177\/25424823251329188","article-title":"Alzheimer's disease and the immune system: a comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy","volume":"9","author":"L","year":"2025","journal-title":"Journal of Alzheimer's Disease Reports"},{"key":"2026092821512343700_ref38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/biomedicines12102319","article-title":"Flow cytometric Immunophenotyping: minimal differences in fresh and cryopreserved peripheral blood mononuclear cells versus whole blood","volume":"12","author":"Tompa","year":"2024","journal-title":"Biomedicines."}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/9\/afag289\/71451535\/afag289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/9\/afag289\/71451535\/afag289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:51:27Z","timestamp":1790646687000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag289\/8842706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag289","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"afag289"}}